| AMTAX | RWIAX | AMTAX / RWIAX | |
| Total Expense Ratio | 1.20 | 1.51 | 79% |
| Annual Report Gross Expense Ratio | 1.24 | 1.51 | 82% |
| Fund Existence | 16 years | 24 years | - |
| Gain YTD | 13.360 | 15.218 | 88% |
| Front Load | 4% | N/A | - |
| Min. Initial Investment | 2500 | 250 | 1,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 763M | 160B | 0% |
| Annual Yield % from dividends | 5.68 | 0.73 | 775% |
| Returns for 1 year | 26.37 | 20.85 | 126% |
| Returns for 3 years | 51.87 | 49.70 | 104% |
| Returns for 5 years | 51.42 | 31.19 | 165% |
| Returns for 10 years | 110.37 | 102.34 | 108% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| CSHZX | 13.70 | 0.15 | +1.11% |
| NYLI Cushing® MLP Premier Class I | |||
| FSMAX | 116.33 | N/A | N/A |
| Fidelity Extended Market Index | |||
| ACIZX | 66.86 | N/A | N/A |
| Alger Capital Appreciation Instl Z-2 | |||
| BIPIX | 80.88 | N/A | N/A |
| ProFunds Biotechnology UltraSector Inv | |||
| TASVX | 22.54 | N/A | N/A |
| PGIM Quant Solutions Small-Cap Val Z | |||